Advanced BioPhotonics, Inc. engages in the acquisition, development, and commercialization of medical imaging technology for the diagnosis and management of various diseases, including cancer and vascular diseases. The companys principal product includes the BioScanIR system, which detects diseases that affect the perfusion or reperfusion of blood in tissues and organs. The BioScanIR system assists physicians and researchers in differentiating between normal and abnormal tissues by detecting small changes in perfusion. Advanced BioPhotonics offers its products primarily in the United States and the European Union. The company, formerly known as OmniCorder Technologies, Inc., was founded in 1997. It changed its name to Advanced BioPhotonics, Inc. in 2005. The company is headquartered in Bohemia, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for ABPH